BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 8943072)

  • 1. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.
    Lin JS; Hou Y; Jouvet M
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14128-33. PubMed ID: 8943072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil.
    Engber TM; Koury EJ; Dennis SA; Miller MS; Contreras PC; Bhat RV
    Neurosci Lett; 1998 Jan; 241(2-3):95-8. PubMed ID: 9507929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of central histaminergic systems in modafinil-induced but not methylphenidate-induced increases in locomotor activity in rats.
    Ishizuka T; Murakami M; Yamatodani A
    Eur J Pharmacol; 2008 Jan; 578(2-3):209-15. PubMed ID: 17920581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the cat.
    Lin JS; Gervasoni D; Hou Y; Vanni-Mercier G; Rambert F; Frydman A; Jouvet M
    J Sleep Res; 2000 Mar; 9(1):89-96. PubMed ID: 10733694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamic arousal regions are activated during modafinil-induced wakefulness.
    Scammell TE; Estabrooke IV; McCarthy MT; Chemelli RM; Yanagisawa M; Miller MS; Saper CB
    J Neurosci; 2000 Nov; 20(22):8620-8. PubMed ID: 11069971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat.
    Lin JS; Roussel B; Akaoka H; Fort P; Debilly G; Jouvet M
    Brain Res; 1992 Sep; 591(2):319-26. PubMed ID: 1359924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates.
    Willie JT; Renthal W; Chemelli RM; Miller MS; Scammell TE; Yanagisawa M; Sinton CM
    Neuroscience; 2005; 130(4):983-95. PubMed ID: 15652995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Armodafinil promotes wakefulness and activates Fos in rat brain.
    Fiocchi EM; Lin YG; Aimone L; Gruner JA; Flood DG
    Pharmacol Biochem Behav; 2009 May; 92(3):549-57. PubMed ID: 19249327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of modafinil and amphetamine on sleep-wake cycle after sleep deprivation in cats.
    Hou YP; Lin JS
    Zhongguo Yao Li Xue Bao; 1999 Sep; 20(9):813-8. PubMed ID: 11245089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine.
    Engber TM; Dennis SA; Jones BE; Miller MS; Contreras PC
    Neuroscience; 1998 Dec; 87(4):905-11. PubMed ID: 9759978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats.
    Quisenberry AJ; Baker LE
    Psychopharmacology (Berl); 2015 Dec; 232(24):4411-9. PubMed ID: 26374456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG.
    Chapotot F; Pigeau R; Canini F; Bourdon L; Buguet A
    Psychopharmacology (Berl); 2003 Mar; 166(2):127-38. PubMed ID: 12552359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The unfinished journey with modafinil and discovery of a novel population of modafinil-immunoreactive neurons.
    Lin JS; Roussel B; Gaspar A; Zhao Y; Hou Y; Schmidt M; Jouvet A; Jouvet M
    Sleep Med; 2018 Sep; 49():40-52. PubMed ID: 30172629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications.
    Boutrel B; Koob GF
    Sleep; 2004 Sep; 27(6):1181-94. PubMed ID: 15532213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice.
    Trinh JV; Nehrenberg DL; Jacobsen JP; Caron MG; Wetsel WC
    Neuroscience; 2003; 118(2):297-310. PubMed ID: 12699766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain pattern of histone H3 phosphorylation after acute amphetamine administration: its relationship to brain c-fos induction is strongly dependent on the particular brain area.
    Rotllant D; Armario A
    Neuropharmacology; 2012 Feb; 62(2):1073-81. PubMed ID: 22063717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat.
    Edgar DM; Seidel WF
    J Pharmacol Exp Ther; 1997 Nov; 283(2):757-69. PubMed ID: 9353396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of stress and amphetamine administration on Fos-like protein expression in corticotropin releasing factor-neurons of the rat brain.
    Rotllant D; Nadal R; Armario A
    Dev Neurobiol; 2007 May; 67(6):702-14. PubMed ID: 17443818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs.
    Shelton J; Nishino S; Vaught J; Dement WC; Mignot E
    Sleep; 1995 Dec; 18(10):817-26. PubMed ID: 8746387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Awakening properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat.
    Touret M; Sallanon-Moulin M; Jouvet M
    Neurosci Lett; 1995 Apr; 189(1):43-6. PubMed ID: 7603622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.